US8022058B2
(en)
|
2000-05-10 |
2011-09-20 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the RyR receptors
|
US7718644B2
(en)
|
2004-01-22 |
2010-05-18 |
The Trustees Of Columbia University In The City Of New York |
Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
|
US7879840B2
(en)
|
2005-08-25 |
2011-02-01 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the RyR receptors
|
MXPA05005425A
(es)
*
|
2002-11-22 |
2005-11-23 |
Japan Tobacco Inc |
Heterociclos que contienen nitrogeno, biciclicos, fusionados.
|
EP1653969A4
(en)
|
2003-08-07 |
2006-12-20 |
Japan Tobacco Inc |
PYRROLO 1,2-B PYRIDAZINE DERIVATIVES
|
US8710045B2
(en)
|
2004-01-22 |
2014-04-29 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the ryanodine receptors
|
JP2007519605A
(ja)
*
|
2004-01-30 |
2007-07-19 |
日本たばこ産業株式会社 |
食欲抑制薬
|
AU2005295453A1
(en)
*
|
2004-10-15 |
2006-04-27 |
Bayer Healthcare Llc |
Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
|
WO2006045096A2
(en)
*
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
|
NZ587106A
(en)
|
2004-12-14 |
2012-03-30 |
Astrazeneca Ab |
Oxadiazole derivatives as dgat inhibitors
|
WO2006082010A1
(en)
|
2005-02-07 |
2006-08-10 |
F.Hoffmann-La Roche Ag |
Inhibitors of diacylglycerol acyltransferase (dgat)
|
US20090264650A1
(en)
*
|
2005-03-31 |
2009-10-22 |
Nobuo Cho |
Prophylactic/Therapeutic Agent for Diabetes
|
WO2006120125A1
(en)
|
2005-05-10 |
2006-11-16 |
F. Hoffmann-La Roche Ag |
Diacylglycerol acyltransferase inhibitors
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
US7723342B2
(en)
*
|
2005-05-17 |
2010-05-25 |
Schering Corporation |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
US7750015B2
(en)
|
2005-05-17 |
2010-07-06 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
CA2610188A1
(en)
*
|
2005-06-11 |
2006-12-21 |
Astrazeneca Ab |
Oxadiazole derivatives as dgat inhibitors
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
US7704990B2
(en)
|
2005-08-25 |
2010-04-27 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the RyR receptors
|
WO2007060140A2
(en)
|
2005-11-28 |
2007-05-31 |
F. Hoffmann-La Roche Ag |
Inhibitors of diacyglycerol acyltransferase (dgat)
|
JPWO2007063839A1
(ja)
*
|
2005-11-30 |
2009-05-07 |
塩野義製薬株式会社 |
シクロヘキサン誘導体
|
US7749997B2
(en)
|
2005-12-22 |
2010-07-06 |
Astrazeneca Ab |
Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors
|
PE20070854A1
(es)
|
2006-01-20 |
2007-09-10 |
Schering Corp |
Compuestos heterociclos como agonistas del receptor de acido nicotinico
|
KR20080103584A
(ko)
*
|
2006-03-30 |
2008-11-27 |
아사히 가세이 파마 가부시키가이샤 |
치환 이환식 환상 유도체 및 그 용도
|
ES2430115T3
(es)
|
2006-03-31 |
2013-11-19 |
Novartis Ag |
Inhibidor de DGAT
|
CA2651663A1
(en)
|
2006-05-30 |
2007-12-06 |
Astrazeneca Ab |
Chemical compounds
|
US8084478B2
(en)
|
2006-05-30 |
2011-12-27 |
Asstrazeneca Ab |
Substituted 5- phenylamino- 1, 3, 4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme A diacylglycerol acyltransferase
|
JP2009539818A
(ja)
|
2006-06-08 |
2009-11-19 |
アストラゼネカ アクチボラグ |
ベンゾイミダゾールおよび糖尿病の処置のためのその使用
|
GB0611506D0
(en)
*
|
2006-06-10 |
2006-07-19 |
Astrazeneca Ab |
Chemical compounds
|
AU2007298286B2
(en)
|
2006-09-19 |
2011-02-03 |
Daiichi Sankyo Company, Limited |
Pyrazolopyrimidine derivative
|
JP2010511058A
(ja)
|
2006-11-29 |
2010-04-08 |
アボット・ラボラトリーズ |
ジアシルグリセロールo−アシルトランスフェラーゼ1型酵素の阻害薬
|
WO2008073865A2
(en)
*
|
2006-12-11 |
2008-06-19 |
Novartis Ag |
Method of preventing or treating myocardial ischemia
|
WO2008090198A1
(en)
*
|
2007-01-25 |
2008-07-31 |
Janssen Pharmaceutica Nv |
Use of mtp inhibitors for increasing levels of satiety hormones
|
PL2118074T3
(pl)
|
2007-02-01 |
2014-06-30 |
Resverlogix Corp |
Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
|
EP2120911A1
(en)
*
|
2007-02-15 |
2009-11-25 |
Prosidion Limited |
Amide and urea derivatives for the treatment of metabolic diseases
|
CN101678011B
(zh)
|
2007-05-16 |
2012-07-18 |
默沙东公司 |
螺氮茚酮化合物
|
US8058299B2
(en)
*
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
US8115011B2
(en)
*
|
2007-05-22 |
2012-02-14 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
US8153644B2
(en)
*
|
2007-05-22 |
2012-04-10 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
US20090099201A1
(en)
*
|
2007-05-22 |
2009-04-16 |
David Robert Bolin |
Diacylglycerol Acyltransferase Inhibitors
|
WO2008148851A1
(en)
*
|
2007-06-08 |
2008-12-11 |
Janssen Pharmaceutica N.V. |
Piperidine/piperazine derivatives
|
JP5443342B2
(ja)
|
2007-06-08 |
2014-03-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ピペリジン/ピペラジン誘導体
|
JO2972B1
(en)
|
2007-06-08 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Piperidine / piperazine derivatives
|
AR066911A1
(es)
|
2007-06-08 |
2009-09-23 |
Janssen Pharmaceutica Nv |
Derivados de piperidina / piperazina
|
US20090036425A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
CA2697551C
(en)
|
2007-09-20 |
2013-03-12 |
Irm Llc |
Piperidine derivatives as modulators of gpr119 activity
|
AR066169A1
(es)
|
2007-09-28 |
2009-07-29 |
Novartis Ag |
Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
|
KR20100099738A
(ko)
|
2007-12-20 |
2010-09-13 |
아스트라제네카 아베 |
Dgat1 억제제로서의 카르바모일 화합물 190
|
WO2009126624A1
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as dgat1 inhibitors
|
US8394823B2
(en)
|
2008-04-11 |
2013-03-12 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as DGAT1 inhibitors
|
JP5579170B2
(ja)
|
2008-06-05 |
2014-08-27 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Dgat阻害剤とppar作動薬を含有する薬剤組み合わせ物
|
ES2532402T3
(es)
|
2008-06-26 |
2015-03-26 |
Resverlogix Corporation |
Métodos de preparación de derivados de quinazolinona
|
US8211884B2
(en)
*
|
2008-08-06 |
2012-07-03 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
WO2010039801A2
(en)
*
|
2008-10-02 |
2010-04-08 |
The J. David Gladstone Institutes |
Methods of treating hepatitis c virus infection
|
US8324385B2
(en)
*
|
2008-10-30 |
2012-12-04 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
EP2367817A4
(en)
*
|
2008-12-03 |
2012-05-09 |
Via Pharmaceuticals Inc |
INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE ENZYME
|
EP2378878A4
(en)
*
|
2008-12-17 |
2012-08-01 |
Via Pharmaceuticals Inc |
INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE
|
ES2542835T3
(es)
|
2009-01-08 |
2015-08-12 |
Resverlogix Corporation |
Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
|
WO2010086820A1
(en)
|
2009-02-02 |
2010-08-05 |
Pfizer Inc. |
4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
|
TW201040174A
(en)
|
2009-02-03 |
2010-11-16 |
Pfizer |
4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one derivatives
|
WO2010089686A1
(en)
|
2009-02-04 |
2010-08-12 |
Pfizer Inc. |
4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives
|
WO2010098344A1
(ja)
|
2009-02-25 |
2010-09-02 |
第一三共株式会社 |
三環性ピラゾロピリミジン誘導体
|
AR076126A1
(es)
*
|
2009-03-18 |
2011-05-18 |
Schering Corp |
Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
|
EP2408454A2
(en)
|
2009-03-18 |
2012-01-25 |
Resverlogix Corp. |
Novel anti-inflammatory agents
|
EP2805951B1
(en)
|
2009-03-20 |
2018-03-14 |
Metabasis Therapeutics, Inc. |
Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof
|
SG174504A1
(en)
|
2009-03-27 |
2011-10-28 |
Bristol Myers Squibb Co |
Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
|
JP5813626B2
(ja)
|
2009-04-22 |
2015-11-17 |
レスバーロジックス コーポレイション |
新規抗炎症剤
|
BRPI1016109A2
(pt)
|
2009-06-19 |
2016-05-17 |
Astrazeneca Ab |
"composto, composição farmacêutica, e, processo para preparar um composto"
|
WO2011014520A2
(en)
|
2009-07-29 |
2011-02-03 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
WO2011031628A1
(en)
|
2009-09-14 |
2011-03-17 |
Schering Corporation |
Inhibitors of diacylglycerol acyltransferase
|
MX2012004078A
(es)
|
2009-10-09 |
2012-07-25 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de gpr119.
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
MA34097B1
(fr)
|
2010-03-30 |
2013-03-05 |
Novartis Ag |
Utilisations d'inhibiteurs de dgat1
|
US8697739B2
(en)
|
2010-07-29 |
2014-04-15 |
Novartis Ag |
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
|
EP2810945A1
(en)
|
2010-08-23 |
2014-12-10 |
Daiichi Sankyo Company, Limited |
Dihydrochloride salt of a tricyclic pyrazolopyrimidine derivative
|
CA2809388A1
(en)
|
2010-08-23 |
2012-03-01 |
Daiichi Sankyo Company, Limited |
Crystal of a free tricyclic pyrazolopyrimidine derivative
|
KR20130013199A
(ko)
|
2011-07-27 |
2013-02-06 |
한미약품 주식회사 |
신규 피리미딘 유도체 및 이를 활성성분으로 포함하는 약학 조성물
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
KR102011641B1
(ko)
|
2011-11-01 |
2019-08-19 |
리스버로직스 코퍼레이션 |
치환된 퀴나졸리논을 위한 경구 즉시 방출 제형
|
JP6083818B2
(ja)
|
2011-11-18 |
2017-02-22 |
ヘプタレス セラピューティクス リミテッドHeptares Therapeutics Limited |
ムスカリンm1受容体アゴニスト
|
FR2986232B1
(fr)
*
|
2012-01-26 |
2014-02-14 |
Sanofi Sa |
Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique
|
WO2013157792A1
(en)
*
|
2012-04-17 |
2013-10-24 |
Hanmi Pharm. Co., Ltd. |
Bicyclic heteroaryl derivative and pharmaceutical composition comprising same
|
US9499482B2
(en)
|
2012-09-05 |
2016-11-22 |
Bristol-Myers Squibb Company |
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
|
WO2014039411A1
(en)
|
2012-09-05 |
2014-03-13 |
Bristol-Myers Squibb Company |
Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
|
WO2014052619A1
(en)
|
2012-09-27 |
2014-04-03 |
Irm Llc |
Piperidine derivatives and compositions as modulators of gpr119 activity
|
WO2014054053A1
(en)
|
2012-10-03 |
2014-04-10 |
Advinus Therapeutics Limited |
Spirocyclic compounds, compositions and medicinal applications thereof
|
WO2014074668A1
(en)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulators of gpr119 and the treatment of disorders related thereto
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
WO2014081995A1
(en)
*
|
2012-11-23 |
2014-05-30 |
Glaxosmithkline Llc |
Novel compounds as diacylglycerol acyltransferase inhibitors
|
MX2015007921A
(es)
|
2012-12-21 |
2016-03-03 |
Zenith Epigenetics Corp |
Compuestos heterociclicos novedosos como inhibidores de bromodominio.
|
TWI719464B
(zh)
|
2013-03-15 |
2021-02-21 |
美商英塞特控股公司 |
作為bet蛋白抑制劑之三環雜環
|
EP3019502B1
(en)
|
2013-07-08 |
2017-05-17 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
WO2015066697A1
(en)
*
|
2013-11-04 |
2015-05-07 |
Forum Pharmaceuticals Inc. |
Fused morpholinopyrimidines and methods of use thereof
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
WO2015095492A1
(en)
|
2013-12-19 |
2015-06-25 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
DK3674302T3
(da)
|
2014-04-23 |
2023-04-03 |
Incyte Holdings Corp |
1h-pyrrolo[2,3-c]pyridin-7(6h)-oner og pyrazolo[3,4-c]pyridin-7(6h)-oner som inhibitorer af bet-proteiner
|
CN105218561B
(zh)
*
|
2014-06-25 |
2018-10-30 |
上海艾力斯医药科技有限公司 |
稠合嘧啶环衍生物、其制备方法及应用
|
US9527864B2
(en)
|
2014-09-15 |
2016-12-27 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
AR102537A1
(es)
|
2014-11-05 |
2017-03-08 |
Flexus Biosciences Inc |
Agentes inmunomoduladores
|
CN104496795B
(zh)
*
|
2014-12-12 |
2016-09-14 |
重庆博腾制药科技股份有限公司 |
一种dgat-1抑制剂中间体的制备方法
|
JO3789B1
(ar)
|
2015-03-13 |
2021-01-31 |
Resverlogix Corp |
التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة
|
WO2017075377A1
(en)
|
2015-10-29 |
2017-05-04 |
Incyte Corporation |
Amorphous solid form of a bet protein inhibitor
|
WO2017205432A1
(en)
*
|
2016-05-23 |
2017-11-30 |
Dai Lu |
Functionalized pyrano[2,3-d]pyrimidin-7-one derivatives and methods for their preparation and use
|
KR102643344B1
(ko)
|
2016-06-20 |
2024-03-07 |
인사이트 코포레이션 |
Bet 저해제의 결정질 고체 형태
|
JP2019528300A
(ja)
*
|
2016-08-26 |
2019-10-10 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
インドールアミン2,3−ジオキシゲナーゼの阻害剤およびその使用方法
|
CN108164548B
(zh)
*
|
2016-12-07 |
2020-09-08 |
四川大学 |
嘧啶并吗啉衍生物及其制备方法和用途
|
US11365191B2
(en)
|
2018-02-28 |
2022-06-21 |
Dart Neuroscience, Llc |
Substituted cyclohexyl compounds as NOP inhibiiors
|
GB201810239D0
(en)
|
2018-06-22 |
2018-08-08 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
GB201819960D0
(en)
|
2018-12-07 |
2019-01-23 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
WO2023085931A1
(en)
|
2021-11-11 |
2023-05-19 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Hepatic organoids
|